Metabolic Peptides

Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors for metabolic and obesity research.

GHRH analogue that stimulates growth hormone release, researched for metabolic regulation and body composition studies.

Mitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and cellular homeostasis.

High-purity (99.60%) CJC-1295 without DAC research peptide. GHRH analogue for growth hormone secretion, pulsatile GH release, and metabolic pathway studies.

High-purity (99.20%) Ipamorelin research peptide. Selective growth hormone secretagogue for GH release, ghrelin receptor binding, and metabolic research applications.

Dual GIP and GLP-1 receptor agonist supplied as a lyophilized reference standard for metabolic pathway and body-composition research. Available in 13 formats from 5mg to 120mg.

Long-acting lipidated amylin analogue (AM833, NNC0174-0833) supplied as a lyophilized reference standard for amylin and calcitonin receptor pharmacology and energy-intake research. Available in 5mg and 10mg vials.

Small-molecule NNMT inhibitor (5-amino-1-methylquinolinium iodide) supplied as a dry-powder reference standard for adipocyte metabolism, NAD+ salvage, and muscle-ageing research in cell and mouse models. Available in 5mg, 10mg, and 50mg vials.

Synthetic C-terminal fragment of human growth hormone (hGH 177-191, hexadecapeptide) supplied as a lyophilized reference standard for adipose lipolysis, fat-oxidation, and energy-balance research. Available in 2mg, 5mg, and 10mg vials.